NEW YORK – DiaSorin said on Tuesday that its first quarter 2023 revenues fell 19 percent year over year on a sharp decline in COVID-19 testing, partially offset by growth in its non-COVID-19-related diagnostics revenues. The Saluggia, Italy-based firm reported revenues of €289.6 million ($317.5 million) for the quarter ended…Read More
DiaSorin Q1 Revenues Fall 19 Percent on COVID Sales Decline
